PL3906934T3 - Zastosowanie Dalarginu w zapobieganiu wirusowym infekcjom dróg oddechowych i zapobieganiu rozwojowi powikłań podczas wirusowych infekcji dróg oddechowych - Google Patents
Zastosowanie Dalarginu w zapobieganiu wirusowym infekcjom dróg oddechowych i zapobieganiu rozwojowi powikłań podczas wirusowych infekcji dróg oddechowychInfo
- Publication number
- PL3906934T3 PL3906934T3 PL20173355.7T PL20173355T PL3906934T3 PL 3906934 T3 PL3906934 T3 PL 3906934T3 PL 20173355 T PL20173355 T PL 20173355T PL 3906934 T3 PL3906934 T3 PL 3906934T3
- Authority
- PL
- Poland
- Prior art keywords
- viral infections
- respiratory viral
- dalargin
- prevention
- development
- Prior art date
Links
- 206010062106 Respiratory tract infection viral Diseases 0.000 title 2
- GDPHPXYFLPDZGH-XBTMSFKCSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[2-[[(2r)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 GDPHPXYFLPDZGH-XBTMSFKCSA-N 0.000 title 1
- 108700029992 Ala(2)-Arg(6)- enkephalin-Leu Proteins 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20173355.7A EP3906934B1 (en) | 2020-05-06 | 2020-05-06 | Application of dalargin for the prevention of viral respiratory infections and prevention of the development of complications during viral respiratory infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3906934T3 true PL3906934T3 (pl) | 2025-02-24 |
Family
ID=70613705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20173355.7T PL3906934T3 (pl) | 2020-05-06 | 2020-05-06 | Zastosowanie Dalarginu w zapobieganiu wirusowym infekcjom dróg oddechowych i zapobieganiu rozwojowi powikłań podczas wirusowych infekcji dróg oddechowych |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210346459A1 (pl) |
| EP (1) | EP3906934B1 (pl) |
| EA (1) | EA202192687A1 (pl) |
| ES (1) | ES3002532T3 (pl) |
| HU (1) | HUE069345T2 (pl) |
| PL (1) | PL3906934T3 (pl) |
| RS (1) | RS66259B1 (pl) |
| WO (1) | WO2021224664A1 (pl) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1475670A1 (ru) * | 1986-03-24 | 1989-04-30 | В.А.Виноградов, М.И.Титов, Н.П.Буглак и Н.Н.Богданов | Способ лечени звенной болезни двенадцатиперстной кишки |
| US8232320B2 (en) * | 1999-04-28 | 2012-07-31 | The Regents Of The University Of Michigan | Antimicrobial nanoemulsion compositions and methods |
| IT1400067B1 (it) * | 2010-05-21 | 2013-05-17 | Molteni & C | Spray nasale liquido contenente naltrexone a bassi dosaggi. |
| RU2436588C1 (ru) * | 2010-07-06 | 2011-12-20 | Общество с ограниченной ответственностью "Биофарм" | Даларгинсодержащая интраназальная композиция и ее применение для лечения заболеваний |
| CN102370673A (zh) * | 2010-08-23 | 2012-03-14 | 王登之 | 苏冰(速效救心)喷雾剂及其制备方法 |
| CA3011015C (en) * | 2016-01-12 | 2024-04-16 | Nortic Holdings Inc. | Betamethasone oral spray formulation and method of use to treat ataxia |
| RU2672888C1 (ru) * | 2018-04-18 | 2018-11-20 | Пивипи Лабс Пте. Лтд. | Противовирусное иммунотропное средство для лечения ОРВИ |
-
2020
- 2020-05-06 PL PL20173355.7T patent/PL3906934T3/pl unknown
- 2020-05-06 HU HUE20173355A patent/HUE069345T2/hu unknown
- 2020-05-06 RS RS20241352A patent/RS66259B1/sr unknown
- 2020-05-06 EP EP20173355.7A patent/EP3906934B1/en active Active
- 2020-05-06 ES ES20173355T patent/ES3002532T3/es active Active
- 2020-05-07 EA EA202192687A patent/EA202192687A1/ru unknown
- 2020-05-07 WO PCT/IB2020/054342 patent/WO2021224664A1/en not_active Ceased
- 2020-05-25 US US16/882,631 patent/US20210346459A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3906934A1 (en) | 2021-11-10 |
| ES3002532T3 (en) | 2025-03-07 |
| RS66259B1 (sr) | 2024-12-31 |
| WO2021224664A1 (en) | 2021-11-11 |
| HUE069345T2 (hu) | 2025-03-28 |
| US20210346459A1 (en) | 2021-11-11 |
| EP3906934B1 (en) | 2024-09-25 |
| EA202192687A1 (ru) | 2022-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3556377T3 (pl) | Dalargin do stosowania w leczeniu ostrych infekcji wirusowych dróg oddechowych | |
| IL289975A (en) | Use of cannabidiol in the treatment of dravet syndrome | |
| EP4466269A4 (en) | PARP1 INHIBITORS AND THEIR USES | |
| SI3759083T1 (sl) | Derivati 2,4-diaminokinazolina in njihova uporaba v zdravljenju virusnih okužb, raka ali alergij | |
| EP4003355A4 (en) | DIHYDROPYRIMIDE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASE | |
| EP4117704A4 (en) | Cxcr4 inhibitor for the treatment of acute respiratory distress syndrome and viral infections | |
| PL3823623T3 (pl) | Podstawiony związek aminopirymidynowy do zastosowania w metodzie leczenia i zapobiegania stwardnieniu rozsianemu | |
| ITUB20160543A1 (it) | Composizione oftalmica stabilizzante e reintegrante del film lacrimale per uso nella prevenzione delle infezioni virali | |
| EP3790866A4 (en) | DIHYDROPYRIMIDINE DERIVATIVES AND THEIR USES IN THE TREATMENT OF HEPATITIS B VIRUS INFECTION OR HEPATITIS B VIRUS INDUCED DISEASES | |
| KR20240101563A9 (ko) | 쇼그렌 증후군의 치료 및 예방을 위한 cd40l-특이적 tn3-유래된 스캐폴드 | |
| GB2607709B (en) | Lens sets for use in preventing or slowing the development or progression of myopia and related methods | |
| IL309355A (en) | Compositions and their use for the treatment of α1-antitrypsin deficiency | |
| HUE069345T2 (hu) | Dalargin alkalmazása vírusos légúti fertõzések megelõzésére és szövõdményeik kialakulásának megelõzésére vírusos légúti fertõzések során | |
| EP4003987A4 (en) | DIHYDROPYRIMIDINE DERIVATIVES AND THEIR USES IN THE TREATMENT OF HEPATITIS B VIRUS INFECTION OR HEPATITIS B VIRUS INDUCED DISEASES | |
| PT3937949T (pt) | Fitoecdisonas e seus derivados para utilização no tratamento da alteração da função respiratória | |
| GB202103578D0 (en) | Prevention and treatment of infections including those caused by coronavirus | |
| LT4110288T (lt) | Vietinė kompozicija, skirta palaikyti ir (arba) atkurti gleivinės ir pažeisto epidermio vientisumą | |
| IT201700034630A1 (it) | Pad2 per uso nella prevenzione e/o trattamento o diagnosi di infezioni da virus della famiglia herpesviridae | |
| ES3066501T3 (en) | Methods and pharmaceutical compositions for treating and preventing acute respiratory distress syndrome associated with viral infections | |
| HUE060482T2 (hu) | Parapoxvírus koronavírus fertõzések kondícionálására és kezelésére | |
| PL3999069T3 (pl) | Synergistyczne działanie eyp001 i pegylowanego ifn-alfa w leczeniu zakażenia hbv | |
| JP1737997S (ja) | ゲーム用ラケット | |
| JP1737996S (ja) | ゲーム用ラケット | |
| EP4003997A4 (en) | DIHYDROPYRIMIDINE DERIVATIVES AND THEIR USES IN THE TREATMENT OF HEPATITIS B VIRUS INFECTION OR HEPATITIS B VIRUS INDUCED DISEASES | |
| HK40085151A (en) | Sars-cov2-specific t cell compositions and their use in treating and preventing coronavirus and other respiratory virus infections |